help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gill, M. S.
Right arrow Articles by Shalet, S. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gill, M. S.
Right arrow Articles by Shalet, S. M.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
The Journal of Clinical Endocrinology & Metabolism Vol. 84, No. 4 1288-1295
Copyright © 1999 by The Endocrine Society


Original Studies

Serum Leptin Response to the Acute and Chronic Administration of Growth Hormone (GH) to Elderly Subjects with GH Deficiency1

Matthew S. Gill, Andrew A. Toogood, Jenny Jones, Peter E. Clayton and Stephen M. Shalet

Endocrine Sciences Research Group, Department of Medicine, University of Manchester, Manchester, United Kingdom M13 9PT; the Department of Endocrinology, Christie Hospital National Health Service Trust (A.A.T., S.M.S.), Withington, Manchester, United Kingdom M20 4BX; and the Department of Medicine, King’s College School of Medicine and Dentistry (J.J.), Denmark Hill, London, United Kingdom SE5 9PJ

Address all correspondence and requests for reprints to: Dr. Peter E. Clayton, Endocrine Sciences Research Group, Department of Medicine, University of Manchester, Oxford Road, Manchester, United Kingdom M13 9PT. E-mail: peter.clayton{at}man.ac.uk

In human studies, the principal determinant of serum leptin concentrations is fat mass (FM), but lean mass (LM) also has a significant negative influence. GH treatment in GH deficiency (GHD) alters body composition, increasing LM and decreasing FM, and thus would be expected to alter leptin concentrations. We have therefore examined the acute and chronic effects of GH on serum leptin in 12 elderly GHD subjects (ages 62–85 yr; 3 women and 9 men). FM (kilograms) and LM (kilograms) were determined by dual energy x-ray absortiometry. Leptin, insulin, insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-1 (IGFBP-1), IGFBP-2, and IGFBP-3 were measured by specific immunoassays. Leptin, insulin, and IGFBP-1 concentrations were log10 transformed, and data were expressed as the geometric mean (-1, +1 tolerance factor). All other data are presented as the mean ± SD.

In the acute study, patients received a single bolus dose of GH (0.1 mg/kg BW) at time zero, with blood samples drawn at 0, 12, 24, 48, and 72 h and 1 and 2 weeks. There was a significant rise in leptin, insulin, and IGF-I at a median time of 24 h, followed by a significant fall, and nadir concentrations were reached at a median time of 1.5 weeks (leptin) or 2 weeks (insulin and IGF-I). IGFBP-3 concentrations were also significantly increased, but peak concentrations were not achieved until 48 h. IGF-II, IGFBP-1, and IGFBP-2 exhibited transient decreases before returning to baseline levels. There was no relationship between increased leptin concentrations and either insulin or IGF-I concentrations.

In the chronic study, patients received daily GH treatment at doses of 0.17, 0.33, and 0.5 mg/day, each for 3 months (total time on GH, 9 months), and were then followed off GH for a further 3 months. Dual energy x-ray absortiometry was undertaken at 0, 3, 6, 9, and 12 months, and blood samples were drawn at these time points. Over 9 months on GH there was a significant fall in FM and a significant rise in LM, but no change in leptin. There were also significant increments in insulin, IGF-I, and IGFBP-3, whereas IGF-II, IGFBP-1, and IGFBP-2 did not change over 9 months of GH treatment. After 3 months off GH, there was a significant rise in FM and leptin.

High dose single bolus GH led to an increase in serum leptin within 24 h apparently independent of changes in insulin or IGF-I. Despite the changes in body composition during chronic GH treatment, there was no change in leptin. However, discontinuation of GH led to a rapid reversal of the favorable body composition and a rise in serum leptin.




This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
T. Munzer, C. J. Rosen, S.M. Harman, K. M. Pabst, C. St. Clair, J. D. Sorkin, and M. R. Blackman
Effects of GH and/or sex steroids on circulating IGF-I and IGFBPs in healthy, aged women and men
Am J Physiol Endocrinol Metab, May 1, 2006; 290(5): E1006 - E1013.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
A. Zafeiridis, I. Smilios, R. V. Considine, and S. P. Tokmakidis
Serum leptin responses after acute resistance exercise protocols
J Appl Physiol, February 1, 2003; 94(2): 591 - 597.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P. Marzullo, C. Buckway, K. L. Pratt, A. Colao, J. Guevara-Aguirre, and R. G. Rosenfeld
Leptin Concentrations in GH Deficiency: The Effect of GH Insensitivity
J. Clin. Endocrinol. Metab., February 1, 2002; 87(2): 540 - 545.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
H. S. Randeva, R. D. Murray, K. C. Lewandowski, C. J. O'Callaghan, R. Horn, P. O'Hare, G. Brabant, E. W. Hillhouse, and S. M. Shalet
Differential Effects of GH Replacement on the Components of the Leptin System in GH-Deficient Individuals
J. Clin. Endocrinol. Metab., February 1, 2002; 87(2): 798 - 804.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. Coutant, F. Boux de Casson, S. Rouleau, O. Douay, E. Mathieu, M. Audran, and J. M. Limal
Body Composition, Fasting Leptin, and Sex Steroid Administration Determine GH Sensitivity in Peripubertal Short Children
J. Clin. Endocrinol. Metab., December 1, 2001; 86(12): 5805 - 5812.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. Coutant, F. Boux de Casson, O. Douay, E. Mathieu, S. Rouleau, F. Beringue, P. Gillard, J. M. Limal, and P. Descamps
Relationships between Placental GH Concentration and Maternal Smoking, Newborn Gender, and Maternal Leptin: Possible Implications for Birth Weight
J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4854 - 4859.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. A. Lissett, P. E. Clayton, and S. M. Shalet
The Acute Leptin Response to GH
J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4412 - 4415.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
L. Ghizzoni, G. Mastorakos, M. E. Street, G. Mazzardo, A. Vottero, M. Vanelli, and S. Bernasconi
Leptin, Cortisol, and GH Secretion Interactions in Short Normal Prepubertal Children
J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3729 - 3734.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1999 by The Endocrine Society